186 related articles for article (PubMed ID: 15317151)
1. The biology and pharmacology of calcium channel alpha2-delta proteins Pfizer Satellite Symposium to the 2003 Society for Neuroscience Meeting. Sheraton New Orleans Hotel, New Orleans, LA November 10, 2003.
Taylor CP
CNS Drug Rev; 2004; 10(2):183-8. PubMed ID: 15317151
[No Abstract] [Full Text] [Related]
2. Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators.
Stahl SM
J Clin Psychiatry; 2004 Aug; 65(8):1033-4. PubMed ID: 15323585
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsants as anxiolytics, part 2: Pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels.
Stahl SM
J Clin Psychiatry; 2004 Apr; 65(4):460-1. PubMed ID: 15119905
[No Abstract] [Full Text] [Related]
4. Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels.
Stahl SM
J Clin Psychiatry; 2004 May; 65(5):596-7. PubMed ID: 15163243
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
Taylor CP; Angelotti T; Fauman E
Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of analgesia by gabapentin and pregabalin--calcium channel alpha2-delta [Cavalpha2-delta] ligands.
Taylor CP
Pain; 2009 Mar; 142(1-2):13-6. PubMed ID: 19128880
[No Abstract] [Full Text] [Related]
7. The mechanisms of action of gabapentin and pregabalin.
Sills GJ
Curr Opin Pharmacol; 2006 Feb; 6(1):108-13. PubMed ID: 16376147
[TBL] [Abstract][Full Text] [Related]
8. Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia.
Hurley RW; Chatterjea D; Rose Feng M; Taylor CP; Hammond DL
Anesthesiology; 2002 Nov; 97(5):1263-73. PubMed ID: 12411814
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel ligands for the gabapentin binding site on the alpha2delta subunit of a calcium channel and their evaluation as anticonvulsant agents.
Bryans JS; Davies N; Gee NS; Dissanayake VU; Ratcliffe GS; Horwell DC; Kneen CO; Morrell AI; Oles RJ; O'Toole JC; Perkins GM; Singh L; Suman-Chauhan N; O'Neill JA
J Med Chem; 1998 May; 41(11):1838-45. PubMed ID: 9599234
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.
Fink K; Dooley DJ; Meder WP; Suman-Chauhan N; Duffy S; Clusmann H; Göthert M
Neuropharmacology; 2002 Feb; 42(2):229-36. PubMed ID: 11804619
[TBL] [Abstract][Full Text] [Related]
11. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels.
Bertrand S; Ng GY; Purisai MG; Wolfe SE; Severidt MW; Nouel D; Robitaille R; Low MJ; O'Neill GP; Metters K; Lacaille JC; Chronwall BM; Morris SJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):15-24. PubMed ID: 11408520
[TBL] [Abstract][Full Text] [Related]
12. 3-substituted GABA analogs with central nervous system activity: a review.
Bryans JS; Wustrow DJ
Med Res Rev; 1999 Mar; 19(2):149-77. PubMed ID: 10189176
[TBL] [Abstract][Full Text] [Related]
13. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin.
Taylor CP; Vartanian MG; Yuen PW; Bigge C; Suman-Chauhan N; Hill DR
Epilepsy Res; 1993 Jan; 14(1):11-5. PubMed ID: 8383597
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ channel alpha2-delta ligands for the treatment of neuropathic pain.
Field MJ; Li Z; Schwarz JB
J Med Chem; 2007 May; 50(11):2569-75. PubMed ID: 17489571
[No Abstract] [Full Text] [Related]
15. Differential modulation of K(+)-evoked (3)H-neurotransmitter release from human neocortex by gabapentin and pregabalin.
Brawek B; Löffler M; Dooley DJ; Weyerbrock A; Feuerstein TJ
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jan; 376(5):301-7. PubMed ID: 18074120
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.
Belliotti TR; Capiris T; Ekhato IV; Kinsora JJ; Field MJ; Heffner TG; Meltzer LT; Schwarz JB; Taylor CP; Thorpe AJ; Vartanian MG; Wise LD; Zhi-Su T; Weber ML; Wustrow DJ
J Med Chem; 2005 Apr; 48(7):2294-307. PubMed ID: 15801823
[TBL] [Abstract][Full Text] [Related]
17. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo.
Bauer CS; Rahman W; Tran-van-Minh A; Lujan R; Dickenson AH; Dolphin AC
Biochem Soc Trans; 2010 Apr; 38(2):525-8. PubMed ID: 20298215
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy.
Wallin J; Cui JG; Yakhnitsa V; Schechtmann G; Meyerson BA; Linderoth B
Eur J Pain; 2002; 6(4):261-72. PubMed ID: 12161092
[TBL] [Abstract][Full Text] [Related]
19. R-phenibut binds to the α2-δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects.
Zvejniece L; Vavers E; Svalbe B; Veinberg G; Rizhanova K; Liepins V; Kalvinsh I; Dambrova M
Pharmacol Biochem Behav; 2015 Oct; 137():23-9. PubMed ID: 26234470
[TBL] [Abstract][Full Text] [Related]
20. The alpha(2)delta subunit augments functional expression and modifies the pharmacology of Ca(V)1.3 L-type channels.
Andrade A; Sandoval A; González-Ramírez R; Lipscombe D; Campbell KP; Felix R
Cell Calcium; 2009 Oct; 46(4):282-92. PubMed ID: 19796812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]